Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
Recent clinical trial results are likely to lead doctors to treat more patients who have a common form of lung cancer with a Merck drug at the expense of a Bristol-Myers Squibb medication at least until more data emerges, oncologists and analysts say. The yet-to-be-published studies involve drugs in a new class designed to enable the body's immune system to fight cancer. A recent trial of Merck's Keytruda showed that it worked better than chemotherapy as an initial treatment for advanced non-small cell lung cancer (NSCLC) in patients with high levels of a protein called PDL1, believed to help identify those most likely to benefit from this type of immunotherapy.

Athletics - Polish Olympian sells Rio medal to save boy battling cancer

Athletics - Polish Olympian sells Rio medal to save boy battling cancer- Polish discus thrower Piotr Malachowski, who took silver at the Rio Olympics, said he auctioned off his medal this week to fund treatment for a three-year-old boy who has cancer. The 33-year-old world champion wrote on his Facebook page he was moved to auction his prize after receiving a letter from the mother of a boy called Olek who said he had been battling eye cancer for two years and treatment in New York was his only hope. "I fought for gold in Rio.



Polish Olympian sells Rio medal to save boy battling cancer

Poland's Piotr Malachowski competes in the men's discus throw qualifying round during the Rio 2016 Olympic GamesPolish discus thrower Piotr Malachowski, who took silver at the Rio Olympics, said that he auctioned off his medal this week to fund treatment for a three-year-old boy struck with cancer. The 33-year-old world champion wrote on his Facebook page that he was moved to auction his prize after receiving a letter from the mother of a boy called Olek who said he had been battling eye cancer for two years and that treatment in New York was his only hope. "I fought for gold in Rio.



LGBT Seniors Are Being Pushed Back Into the Closet
A few years ago, Rabbi Sara Paasche-Orlow was spending time with, and comforting, a friend who was dying of cancer. Along with all of the usual difficulties and complexities of end-of-life care, there was an additional concern for the friend. Despite being married to her lesbian partner, she didn’t feel like she could be open about it with the hospice worker.

America's No. 1 Killer Is Changing
Cancer has passed heart disease as the leading cause of death in nearly half of U.S. states, according to a new report. In 2014, cancer was the leading cause of death in 22 states, including many in the West and Northeast. In the rest of the 28 states, heart disease remained the leading cause of death in 2014.

What Dogs Can Teach Us About OCD and Cancer

What Dogs Can Teach Us About OCD and CancerDogs are helping geneticists decode human disease.



Being overweight linked to eight more kinds of cancer

Being overweight linked to eight more kinds of cancerBeing overweight can raise the likelihood of being diagnosed with cancers of the stomach and digestive tract, as well as certain brain and reproductive tumors, international researchers said Wednesday. A report in the New England Journal of Medicine adds eight more kinds of cancer to the list of those already known to be more likely among overweight people. In 2002, the World Health Organization's International Agency for Cancer on Research (IARC), based in France, said excess pounds could raise the risk of colon, esophagus, kidney, breast and uterine cancer.



A Tart Splash Of Vinegar Isn't Just for Salad

A Tart Splash Of Vinegar Isn't Just for SaladThe newest magic elixir is among the world’s oldest. I’m talking vinegar here, touted online and in actual, physical books as a miracle cure for everything from athlete’s foot and bee stings to heart disease, diabetes, and cancer.



Former head of Kenyan athletics dies amid corruption probe

Isaiah Kiplagat ran Athletics Kenya for 23 years but was suspended in a corruption scandal which was still under investigation when he diedThe former head of athletics in Kenya, under investigation for corruption and a doping coverup, died on Wednesday aged 72, his family said. Isaiah Kiplagat ran Athletics Kenya for 23 years, but his career ended in disgrace in November when he was suspended along with two others, accused of corruption and covering up doping among Kenyan runners, over 40 of whom have been banned since 2012. Family members said the former International Association of Athletics Federations (IAAF) council member had been suffering from cancer and died on Wednesday morning.



AstraZeneca sells part of antibiotics unit to Pfizer

AstraZeneca rejected a $116-billion takeover bid from Pfizer two years agoBritish drugs giant AstraZeneca on Wednesday agreed to sell part of its antibiotics business to US giant Pfizer for up to $1.6 billion (1.4 billion euros). The deal for the company's small-molecule antibiotics, or those developed using traditional chemistry, is expected to complete in the fourth quarter, AstraZeneca said in a statement. The news comes days after Pfizer bought San Francisco-based biotech firm Medivation, which specialises in cancer treatments, for $14 billion.



Pfizer to buy antibiotics business from AstraZeneca

The Pfizer logo is seen at their world headquarters in New YorkPharmaceutical company AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer Inc in a deal that could be valued at more than $1.5 billion. AstraZeneca, which saw off a $120 billion takeover attempt by Pfizer in 2014, said the sale would allow it to focus on developing new medicines in its main areas of cancer, and respiratory and cardiovascular diseases. The U.S. company, which on Monday bought cancer drug firm Medivation for $14 billion in cash, said the antibiotics would enhance its portfolio of more than 60 anti-infective and anti-fungal medicines.



France's Burkini Ban Backfires: Non-Muslim Women Suit Up
Sales of the covered-up styles spike thanks to skin cancer survivors.

1    2    3    4    Next